Semi-Permeable Membrane Retention of Synovial Fluid Lubricants Hyaluronan and Proteoglycan 4 for a Biomimetic Bioreactor

被引:19
作者
Blewis, Megan E. [1 ]
Lao, Brian J. [1 ]
Jadin, Kyle D. [2 ]
McCarty, William J. [1 ]
Bugbee, William D. [3 ]
Firestein, Gary S. [4 ]
Sah, Robert L. [1 ,5 ,6 ]
机构
[1] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA
[2] WL Gore & Assoc Inc, Flagstaff, AZ USA
[3] Univ Calif San Diego, Dept Orthopaed Surg, Sch Med, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, Sch Med, La Jolla, CA 92093 USA
[5] Univ Calif San Diego, Ctr Musculoskeletal Res, La Jolla, CA 92093 USA
[6] Univ Calif San Diego, Whitaker Ctr Biomed Engn, Inst Engn Med, La Jolla, CA 92093 USA
关键词
synovial fluid; hyaluronan; proteoglycan; 4; synoviocytes; semi-permeable membrane; expanded polytetrafluoroethylene (ePTFE); FIBROBLAST-LIKE SYNOVIOCYTES; RHEUMATOID-ARTHRITIS; ARTICULAR-CARTILAGE; MOLECULAR-WEIGHT; RABBIT KNEE; IN-VITRO; SUPERFICIAL ZONE; JOINTS; TISSUE; EXPRESSION;
D O I
10.1002/bit.22645
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Synovial fluid (SF) contains lubricant macromolecules, hyaluronan (HA), and proteoglycan 4 (PRG4). The synovium not only contributes lubricants to SF through secretion by synoviocyte lining cells, but also concentrates lubricants in SF due to its semi-permeable nature. A membrane that recapitulates these synovium functions may be useful in a bioreactor system for generating a bioengineered fluid (BF) similar to native SF. The objectives were to analyze expanded polytetrafluoroethylene membranes with pore sizes of 50 nm, 90 nm, 170 nm, and 3 mu m in terms of (1) HA and PRG4 secretion rates by adherent synoviocytes, and (2) the extent of HA and PRG4 retention with or without synoviocytes adherent on the membrane: Experiment I: Synoviocytes were cultured on tissue culture (TC) plastic or membranes +/- IL-1 beta TGF-beta 1 + TNF-alpha, a cytokine combination that stimulates lubricant synthesis. HA and PRG4 secretion rates were assessed by analysis of medium. Experiment 2: Bioreactors were fabricated to provide a BF compartment enclosed by membranes +/- adherent synoviocytes, and an external compartment of nutrient fluid (NF). A solution with HA (1 mg/mL, MW ranging from 30 to 4,000 kDa) or PRG4 (50 mu g/mL) was added to the BF compartment, and HA and PRG4 loss into the NF compartment after 2, 8, and 24 h was determined. Lubricant loss kinetics were analyzed to estimate membrane permeability. Experiment 1: Cytokine-regulated HA and PRG4 secretion rates on membranes were comparable to those on TC plastic. Experiment2: Transport of HA and PRG4 across membranes was lowest with 50 nm membranes and highest with 3 mu m membranes, and transport of high MW HA was decreased by adherent synoviocytes (for 50 and 90 nm membranes). The permeability to HA mixtures for 50 nm membranes was similar to 20 x 10(-8) cm/s (- cells) and similar to 5 x 10(-8) cm/s (+ cells), for 90 nm membranes was similar to 35 x 10(-8) cm/s (- cells) and similar to 19 x 10(-8) cm/s (+ cells), for 170 nm membranes was similar to 74 x 10(-8) cm/s (+/- cells), and for 3 mu m membranes was similar to 139 x 10(-8) cm/s (+/- cells). The permeability of 450 kDa HA was similar to 40x lower than that of 30 kDa HA for 50 nm membranes, but only similar to 2.5x lower for 3 mu m membranes. The permeability of 4,000 kDa HA was similar to 250x lower than that of 30 kDa HA for 50 nm membranes, but only x lower for 3 mu m membranes. The permeability for PRG4 was similar to 4 x 10(-8) cm/s for 50 nm membranes, similar to 48 x 10(-8) cm/s for 90 nm membranes, similar to 144 x 10(-8) cm/s for 170 nm membranes, and similar to 336 x 10(-8) cm/s for 3 mu m membranes. The associated loss across membranes after 24 h ranged from 3% to 92% for HA, and from 3% to 93% for PRG4. These results suggest that semi-permeable membranes may be used in a bioreactor system to modulate lubricant retention in a bioengineered SF, and that synoviocytes adherent on the membranes may serve as both a lubricant source and a barrier for lubricant transport. Biotechnol. Bioeng. 2010;106: 149-160. (C) 2009 Wiley Periodicals, Inc.
引用
收藏
页码:149 / 160
页数:12
相关论文
共 66 条
[1]   Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions [J].
Afify, Alaa ;
Lynne, Lin-Chang ;
Howell, Lydia .
DIAGNOSTIC CYTOPATHOLOGY, 2007, 35 (02) :105-110
[2]   PERMEABILITY CHARACTERISTICS OF CULTURED ENDOTHELIAL-CELL MONOLAYERS [J].
ALBELDA, SM ;
SAMPSON, PM ;
HASELTON, FR ;
MCNIFF, JM ;
MUELLER, SN ;
WILLIAMS, SK ;
FISHMAN, AP ;
LEVINE, EM .
JOURNAL OF APPLIED PHYSIOLOGY, 1988, 64 (01) :308-322
[3]   CYTOKINES IN CHRONIC INFLAMMATORY ARTHRITIS .5. MUTUAL ANTAGONISM BETWEEN INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA ON HLA-DR EXPRESSION, PROLIFERATION, COLLAGENASE PRODUCTION, AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION BY RHEUMATOID-ARTHRITIS SYNOVIOCYTES [J].
ALVAROGRACIA, JM ;
ZVAIFLER, NJ ;
FIRESTEIN, GS .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (06) :1790-1798
[4]  
[Anonymous], 1971, PRINCIPLES POLYM CHE
[5]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[6]   Molecular weight-dependent effects of hyaluronate on the arthritic synovium [J].
Asari, A ;
Miyauchi, S ;
Matsuzaka, S ;
Ito, T ;
Kominami, E ;
Uchiyama, K .
ARCHIVES OF HISTOLOGY AND CYTOLOGY, 1998, 61 (02) :125-135
[7]  
Balazs E.A., 1974, Disorders of the Knee, P63
[8]  
BARTOK B, 2009, IMMUNOL REV IN PRESS
[9]  
Bellon J M, 1993, Ann Vasc Surg, V7, P549, DOI 10.1007/BF02000149
[10]   Synovial fluid cytokines and eicosanoids as markers of joint disease in horses [J].
Bertone, AL ;
Palmer, JL ;
Jones, J .
VETERINARY SURGERY, 2001, 30 (06) :528-538